Symbol="AKRO"
AssetType="Common Stock"
Name="Akero Therapeutics Inc"
Description="Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, is dedicated to developing medications designed to restore metabolic balance and improve overall health. The company is headquartered in South San Francisco, California."
CIK="1744659"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="170 HARBOR WAY, SOUTH SAN FRANCISCO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="2414958000"
EBITDA="-117815000"
PERatio="None"
PEGRatio="None"
BookValue="6.52"
DividendPerShare="0"
DividendYield="0"
EPS="-2.63"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.284"
ReturnOnEquityTTM="-0.494"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-2.63"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="59.86"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="6.03"
EVToRevenue="-"
EVToEBITDA="-14.1"
Beta="-0.927"
num_52WeekHigh="58.38"
num_52WeekLow="10.47"
num_50DayMovingAverage="46.92"
num_200DayMovingAverage="44.72"
SharesOutstanding="55326000"
DividendDate="None"
ExDividendDate="None"
symbol="AKRO"
open="43.55"
high="43.70"
low="41.63"
price="42.97"
volume="779238.00"
latest_trading_day="2023-08-08"
previous_close="43.65"
change="-0.68"
change_percent="-1.5578%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="47"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="53"
Volume_recent_avg="687757"
Change_recent_avg="0.03"
Delta_recent_avg="2.12"
Variance_recent_avg="1.06"
Change_ratio_recent_avg="0.01"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="53"
Aroon_momentum_negative="47"
image_negative_thumbnail_id_1="1127"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0160.jpeg"
image_negative_thumbnail_id_2="133"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0043.jpeg"
image_neutral_thumbnail_id_1="538"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0061.jpeg"
image_neutral_thumbnail_id_2="539"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0060.jpeg"
image_positive_thumbnail_id_1="635"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0073.jpeg"
image_positive_thumbnail_id_2="660"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0048.jpeg"
image_professor_thumbnail_id_1="1193"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0027.jpeg"
image_professor_thumbnail_id_2="1188"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
